We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCIH
1201
DELISTED
Chinacache International Holdings Ltd
CCIH
$148K ﹤0.01%
57,749
+34,385
+147% +$111K
LFWD icon
1202
ReWalk Robotics
LFWD
$19.7M
$145K ﹤0.01%
+25
New +$191K
IRR
1203
DELISTED
VOYA NATURAL RESOURCES EQUITY INCOME FUND
IRR
$145K ﹤0.01%
22,516
+12,091
+116% +$80K
CBA
1204
DELISTED
ClearBridge American Energy MLP
CBA
$145K ﹤0.01%
15,750
+3,500
+29% +$30.7K
ANH
1205
DELISTED
Anworth Mortgage Asset Corporation
ANH
$143K ﹤0.01%
27,750
-31,000
-53% -$157K
SPPP
1206
Sprott Physical Platinum and Palladium Trust
SPPP
$587M
$138K ﹤0.01%
20,043
-1,100
-5% -$7.75K
MARK
1207
DELISTED
Remark Holdings, Inc.
MARK
$137K ﹤0.01%
3,500
CROX icon
1208
Crocs
CROX
$6.14B
$136K ﹤0.01%
19,865
-2,927
-13% -$22.7K
KND
1209
DELISTED
Kindred Healthcare
KND
$134K ﹤0.01%
17,000
-16,000
-48% -$131K
AQMS icon
1210
Aqua Metals
AQMS
$10.2M
$133K ﹤0.01%
51
-30
-37% -$65.6K
NRO
1211
Neuberger Real Estate Securities Income Fund Inc
NRO
$193M
$133K ﹤0.01%
+26,043
New +$132K
BSBR icon
1212
Santander
BSBR
$37.8B
$132K ﹤0.01%
+15,498
New +$116K
PIR
1213
DELISTED
Pier 1 Imports, Inc.
PIR
$132K ﹤0.01%
776
-410
-35% -$47.5K
AWF
1214
AllianceBernstein Global High Income Fund
AWF
$872M
$130K ﹤0.01%
+10,277
New +$126K
PCK
1215
DELISTED
Pimco California Municipal Income Fund II
PCK
$129K ﹤0.01%
13,960
+198
+1% +$1.91K
GGN
1216
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$770M
$127K ﹤0.01%
23,900
+6,771
+40% +$39.1K
LUMO
1217
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$125K ﹤0.01%
1,356
-277
-17% -$31.2K
AACG
1218
ATA Creativity
AACG
$39.6M
$124K ﹤0.01%
33,328
TXMD icon
1219
TherapeuticsMD
TXMD
$23.5M
$123K ﹤0.01%
+426
New +$132K
JPS
1220
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$123K ﹤0.01%
13,211
+1,500
+13% +$13.6K
IMMU
1221
DELISTED
Immunomedics Inc
IMMU
$120K ﹤0.01%
32,770
GMZ
1222
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$116K ﹤0.01%
1,714
-179
-9% -$11.8K
QNST icon
1223
QuinStreet
QNST
$890M
$114K ﹤0.01%
30,350
OCLR
1224
DELISTED
Oclaro Inc.
OCLR
$109K ﹤0.01%
+12,205
New +$105K
SBI
1225
Western Asset Intermediate Muni Fund
SBI
$107M
$105K ﹤0.01%
+11,000
New +$109K

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.